Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 94.81M
June 30, 2026 83.98M
March 31, 2026 82.72M
December 31, 2025 79.63M
September 30, 2025 78.40M
June 30, 2025 77.81M
March 31, 2025 77.08M
December 31, 2024 77.01M
September 30, 2024 68.39M
June 30, 2024 68.31M
March 31, 2024 61.42M
December 31, 2023 61.39M
September 30, 2023 59.06M
June 30, 2023 58.98M
March 31, 2023 56.68M
December 31, 2022 56.63M
September 30, 2022 49.74M
June 30, 2022 49.30M
March 31, 2022 47.34M
December 31, 2021 47.21M
Date Value
September 30, 2021 46.86M
June 30, 2021 46.73M
March 31, 2021 46.57M
December 31, 2020 46.38M
September 30, 2020 40.31M
June 30, 2020 40.28M
March 31, 2020 36.67M
December 31, 2019 36.65M
September 30, 2019 31.72M
June 30, 2019 31.66M
March 31, 2019 31.66M
December 31, 2018 31.64M
September 30, 2018 31.55M
June 30, 2018 31.84M
March 31, 2018 31.84M
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017 31.84M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
PepGen Inc. 69.26M
Oncolytics Biotech, Inc. 132.21M
Sangamo Therapeutics, Inc. 414.27M
Sarepta Therapeutics, Inc. 107.23M
Anixa Biosciences, Inc. 34.58M